Guardant Health
GH
#2669
Rank
S$6.76 B
Marketcap
$54.81
Share price
-4.25%
Change (1 day)
115.60%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Earnings for Guardant Health (GH)

Earnings in 2024 (TTM): -S$0.59 Billion

According to Guardant Health 's latest financial reports the company's current earnings are S$0.73 Billion. , an increase over its 2023 earnings that were of -S$0.65 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Guardant Health from 2018 to 2024

Annual earnings

Year Earnings Change
2024 -S$0.59 Billion-9.12%
2023 -S$0.65 Billion-26.73%
2022 -S$0.88 Billion69.96%
2021 -S$0.52 Billion56.35%
2020 -S$0.34 Billion252.69%
2019 -S$93.82 Million-17.22%
2018 -S$0.12 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-S$0.29 Billion-51.17%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$0.68 Billion 15.93%๐Ÿ‡บ๐Ÿ‡ธ USA